Literature DB >> 24682881

Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells.

Raj Kumar Duary1, Virender Kumar Batish, Sunita Grover.   

Abstract

The relative expression of mucin, pro- and anti-inflammatory genes besides other signaling molecules in HT-29 cells by two test probiotic strains of Lactobacillus plantarum Lp9 and Lp91 and the reference strain L. plantarum 5276 was evaluated by RT-qPCR using Relative Expression Software Tool qBase-Plus under in vitro simulated gut conditions. Ten house keeping genes were evaluated by using geNorm 3.4 excel based application. The most stable genes were RPL27, ACTB and B2M which were subsequently used for calculating the normalization factor. Under pretreatment conditions (4 h probiotic treatment, followed by lipopolysaccharide challenge for 3 h), all the three strains evoked downregulation of IL-8 expression by ~100 %, while in case of TNF-α, the downregulation of the relative gene expression was at the rate of 98.2, 93.8 and 98.0 % with Lp5276, Lp9 and Lp91, respectively, under the same set of conditions. Lp91 evoked maximum downregulation of IL12p35 and IFN-γ with corresponding fold reduction in relative expression of the two genes by 96.5 and 96.7 % during pre-treatment conditions. However, IL-10 and IFN-α were significantly upregulated to the extent of 8.13 ± 0.36 and 2.62 ± 0.14 fold by Lp91 under the same conditions. Lp9 and Lp91 were also quite effective in inducing the expression of Cox-1 and Cox-2 in HT-29 cells as can be reflected from their ratios, i.e., 5.90 and 6.50 (under pretreatment conditions); 3.79 and 4.36 (under co-culture conditions). Thus, the two putative indigenous L. plantarum strains Lp9 and Lp91 demonstrated immunomodulating functions in HT-29 cells at significant levels under different experimental conditions.

Entities:  

Year:  2014        PMID: 24682881      PMCID: PMC4026434          DOI: 10.1007/s12263-014-0398-2

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  68 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Diet, gut microbiota and immune responses.

Authors:  Kendle M Maslowski; Charles R Mackay
Journal:  Nat Immunol       Date:  2011-01       Impact factor: 25.606

3.  Probiotics: not just for treatment anymore.

Authors:  Cornelius W Van Niel
Journal:  Pediatrics       Date:  2005-01       Impact factor: 7.124

Review 4.  Probiotic effects on inflammatory bowel disease.

Authors:  Barbara Sheil; Fergus Shanahan; Liam O'Mahony
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

5.  Application of genomeceuticals to the molecular and immunological aspects of autism.

Authors:  M A Brudnak
Journal:  Med Hypotheses       Date:  2001-08       Impact factor: 1.538

6.  Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria.

Authors:  Karine Vidal; Anne Donnet-Hughes; Dominique Granato
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Expression of the atpD gene in probiotic Lactobacillus plantarum strains under in vitro acidic conditions using RT-qPCR.

Authors:  Raj Kumar Duary; Virender Kumar Batish; Sunita Grover
Journal:  Res Microbiol       Date:  2010-04-21       Impact factor: 3.992

8.  Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.

Authors:  Hye-Sung Lee; Song-Yi Han; Eun-Ah Bae; Chul-Sung Huh; Young-Tae Ahn; Jung-Hee Lee; Dong-Hyun Kim
Journal:  Int Immunopharmacol       Date:  2008-02-05       Impact factor: 4.932

9.  Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells.

Authors:  Raj Kumar Duary; Yudhishthir Singh Rajput; Virender Kumar Batish; Sunita Grover
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  11 in total

Review 1.  Investigating a holobiont: Microbiota perturbations and transkingdom networks.

Authors:  Renee Greer; Xiaoxi Dong; Andrey Morgun; Natalia Shulzhenko
Journal:  Gut Microbes       Date:  2016-03-16

2.  Evaluating the Probiotic Potential of Lactobacillus plantarum Strains from Algerian Infant Feces: Towards the Design of Probiotic Starter Cultures Tailored for Developing Countries.

Authors:  Chahira Gheziel; Pasquale Russo; Mattia Pia Arena; Giuseppe Spano; Hadda-Imene Ouzari; Omar Kheroua; Djamel Saidi; Daniela Fiocco; Hanane Kaddouri; Vittorio Capozzi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

3.  Bacillus amyloliquefaciens Enriched Camel Milk Attenuated Colitis Symptoms in Mice Model.

Authors:  Ashraf Khalifa; Abdullah Sheikh; Hairul Islam Mohamed Ibrahim
Journal:  Nutrients       Date:  2022-05-08       Impact factor: 6.706

4.  Probiotic Pediococcus acidilactici strain from tomato pickle displays anti-cancer activity and alleviates gut inflammation in-vitro.

Authors:  Anuradha Barigela; Bhima Bhukya
Journal:  3 Biotech       Date:  2021-01-03       Impact factor: 2.406

5.  Oral administration of Faecalibacterium prausnitzii and Akkermansia muciniphila strains from humans improves atopic dermatitis symptoms in DNCB induced NC/Nga mice.

Authors:  Yoonmi Lee; Hye Rim Byeon; Seo-Yul Jang; Moon-Gi Hong; Dohak Kim; Dokyung Lee; Joo-Hyun Shin; Yesol Kim; Seung-Goo Kang; Jae-Gu Seo
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

6.  Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1.

Authors:  Ritu Chauhan; Aparna Sudhakaran Vasanthakumari; Harsh Panwar; Rashmi H Mallapa; Raj Kumar Duary; Virender Kumar Batish; Sunita Grover
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

7.  Probiotic Cell-Free Supernatants Exhibited Anti-Inflammatory and Antioxidant Activity on Human Gut Epithelial Cells and Macrophages Stimulated with LPS.

Authors:  Stefania De Marco; Marzia Sichetti; Diana Muradyan; Miranda Piccioni; Giovanna Traina; Rita Pagiotti; Donatella Pietrella
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-04       Impact factor: 2.629

8.  Probiotic Propionibacterium freudenreichii requires SlpB protein to mitigate mucositis induced by chemotherapy.

Authors:  Fillipe Luiz Rosa do Carmo; Houem Rabah; Barbara Fernandes Cordeiro; Sara Heloisa da Silva; Rafaela Miranda Pessoa; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Valérie Gagnaire; Martine Deplanche; Bruna Savassi; Alessandra Figueiroa; Emiliano Rosa Oliveira; Caio César Fonseca; Maria Izabel Alves Queiroz; Núbia Morais Rodrigues; Sávio Henrique de Cicco Sandes; Álvaro Cantini Nunes; Luisa Lemos; Juliana de Lima Alves; Ana Maria Caetano Faria; Ênio Ferreira; Yves Le Loir; Gwénaël Jan; Vasco Azevedo
Journal:  Oncotarget       Date:  2019-12-31

9.  Ancylostoma ceylanicum infective third-stage larvae are activated by co-culture with HT-29-MTX intestinal epithelial cells.

Authors:  Caitlin M Feather; John M Hawdon; John C March
Journal:  Parasit Vectors       Date:  2017-12-15       Impact factor: 3.876

10.  A human origin strain Lactobacillus acidophilus DDS-1 exhibits superior in vitro probiotic efficacy in comparison to plant or dairy origin probiotics.

Authors:  Ravichandra Vemuri; Tanvi Shinde; Madhur D Shastri; Agampodi Promoda Perera; Stephen Tristram; Christopher J Martoni; Rohit Gundamaraju; Kiran D K Ahuja; Madeleine Ball; Rajaraman Eri
Journal:  Int J Med Sci       Date:  2018-05-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.